Thanks to advances in techniques for culturing and genetically modifying patient cells, scientists developed myriad stem cell-based treatments for human diseases. Therapeutic success rates for stem cell-based treatments depend on whether scientists can provide the proper structural and molecular cues to form the cell types lacking in patients. In addition, to support successful engraftment, researchers must devise ways to bypass immune rejection.
In this webinar brought to you by The Scientist’s Creative Services Team, Kim Vanuytsel and Ryan Flannigan discuss the cutting-edge technologies they incorporate to improve stem cell-based therapies for various disorders, including cancer and infertility.
Topics to be covered
Multi-omic profiling reveals a molecular signature of human fetal liver hematopoietic stem cell engraftment potential
Developing in vitro platforms to restore sperm production using 3-D bio-printing
Tuesday, August 9, 2022
3:00 - 4:30 PM Eastern Time
This webinar will also be available on-demand.
Meet the speakers
Kim Vanuytsel, PhD Research Assistant Professor Department of Medicine Center for Regenerative Medicine Boston University School of Medicine
Ryan Flannigan, MD
Assistant Professor Department of Urologic Sciences University of British Columbia Adjunct Clinical Assistant Professor Department of Urology Weill Cornell Medicine
Sponsored by
Register
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
